EMA (EU)
GUIDANCE FINAL
Draft guideline on user safety for pharmaceutical veterinary medicinal products - Revision 2
Published: 9/18/2026Detected: 9/18/2026
Summary preview
Sets out an EMA/CVMP user risk assessment framework for pharmaceutical veterinary medicinal products, outlining how sponsors should identify hazards, estimate user exposure, characterize risk, and implement mitigation…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountsafety
labeling
manufacturing
#user risk assessment
#veterinary medicinal products
#exposure scenarios
#hazard identification
#toxicity data
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026